VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE

DENGUE VACCINE FORMULATION

SYNTHETIC CHIMERIC POXVIRUSES

NOVEL VSV VIRUS FORMULATIONS

RSV Vaccines with Truncated G-Protein Mucin Domains

VIRUS ATTENUATION

NOBLE COLD-ADAPTED ATTENUATED MERS-COV

USE OF DENGUE VACCINE IN PREGNANT AND/OR BREASTFEEDING SUBJECTS

METHOD OF VACCINATION WITH AN ATTENUATED RSV VACCINE FORMULATION

MODULAR BACTERIOPHAGE T4 NANOPARTICLE PLATFORM ENABLES RAPID DESIGN OF DUAL COVID-19-FLU MUCOSAL VACCINES

Mammalian Cell Line for the Production of Modified Vaccinia Virus Ankara (MVA)

Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same

METHODS OF VACCINATING PIGS AGAINST PSEUDORABIES VIRUS

SYNTHETIC CHIMERIC POXVIRUSES

HERPESVIRUS COMPOSITIONS AND RELATED METHODS

ADENOVIRAL VECTOR VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS, AND PREPARATION METHOD THEREFOR AND USE THEREOF

PREFUSION RSV F PROTEINS AND THEIR USE

SARS-COV-2 LACKING THE ENVELOPE PROTEIN AS AN ATTENUATED VACCINE VIRUS AGAINST COVID-19

Alphavirus (Mayaro virus) Constructs Attenuated for Human and Method of its Use

PREFUSION RSV F PROTEINS AND THEIR USE

RECOMBINANT HERPES SIMPLEX VIRUS-2 EXPRESSING GLYCOPROTEIN D AND B ANTIGENS

ADENOVIRAL VECTOR-BASED VACCINE FOR EMERGING VIRUSES

COMPOSITIONS AND METHODS FOR INCREASING VIRAL NUCLEOCAPSID PROTEIN DIMERIZATION

PORCINE ENDOGENOUS RETROVIRUS (PERV)-FREE PORCINE CIRCOVIRUS TYPE 2D-BASED VACCINES AND METHODS OF USE

VIRAL PREPARATIONS AND METHODS FOR TREATING AND MODULATING MITOCHONDRIAL EFFECTS OF CORONAVIRUS INFECTIONS.

LIVE-ATTENUATED SARS-COV-2 VACCINE

DEOPTIMIZED INFLUENZA VIRUSES AND METHODS OF TREATING CANCER

STABILIZATION OF VIRUS-BASED THERAPEUTIC AGENT

ONE-TO-STOP ATTENUATED SARS-COV-2 VIRUS

LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF

Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens

NON-REPLICATING BOVINE INFECTIOUS LYMPHOMA VIRUS (BLV) AND CELLS FOR PRODUCING SAME

RECOMBINANT ROTAVIRUS EXPRESSING EXOGENOUS PROTEIN AND USES THEREOF

RECOMBINANT CEDAR VIRUS CHIMERAS

MODIFIED ONCOLYTIC PARVOVIRUS H-1PV WITH AN ENHANCED FITNESS AND SUPERIOR ANTICANCER ACTIVITY

SELF-AMPLIFYING mRNA VACCINE BASED ON Z7 GENOME

DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS

COMPOSITIONS AND METHODS OF VACCINATION AGAINST DENGUE VIRUS IN CHILDREN AND YOUNG ADULTS

LIVE ATTENUATED JUNIN VIRUS AND RELATED COMPOSITIONS AND METHODS

NOVEL RNA AND DNA TECHNOLOGY FOR VACCINATION AGAINST ALPHAVIRUSES AND OTHER EMERGING AND EPIDEMIC VIRUSES

MULTIVALENT MOPEVAC-BASED IMMUNOGENIC COMPOSITION FOR VACCINATION AGAINST NEW WORLD ARENAVIRUSES AND THERAPEUTIC USE(S) THEREOF

ATTENUATED BORDETELLA BRONCHISEPTICA STRAINS, ORAL VACCINES CONTAINING THE ATTENUATED STRAINS, AND METHODS OF MAKING & USE THEREOF

VACCINE COMPOSITION AGAINST TWO RESPIRATORY VIRUSES

DENGUE VACCINE BATCH MIXING PROCESS

RECOMBINANT ROTA VIRUS EXPRESSION SYSTEM AND RECOMBINANT ROTA VIRUSES

HEPATITIS A VIRUS PREPARATION METHOD AND HEPATITIS A VIRUS PREPARED ACCORDING TO METHOD

ATTENUATED SARS-COV-2

LARGE-SCALE FLAVIVIRAL VACCINE PRODUCTION AND MANUFACTURE

METHOD FOR INHIBITING ZOPHOBAS MORIO BLACK WASTING DISEASE

LARGE-SCALE FLAVIVIRAL VACCINE PRODUCTION AND MANUFACTURE

RECOMBINANT LIVE ATTENUATED RSV VACCINE STRAIN AND PRODUCTION METHOD THEREFOR

Chimeric Flavivirus Lyssavirus Vaccines

INFLUENZA VIRUS MUTANTS AND USES THEREFOR

METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOGENIC CHIKUNGUNYA VIRUS CHIKV-DELTA5NSP3

FREEZE-DRIED VIRAL COMBINATION VACCINE COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF

STABILISED LIQUID VACCINES OF LIVE VIRUSES

VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RNA VIRUSES

COMBINATION THERAPY WITH ARENAVIRUS PARTICLES AND IMMUNE CHECKPOINT MODULATORS OR CYTOKINES

PARENTERALLY ADMINISTRABLE INFLUENZA VACCINE AND USES THEREOF

CORONAVIRUS DERIVED RNA REPLICONS AND THEIR USE AS VACCINES

Zika Virus Vaccine

Compositions and Methods for Dengue Virus Chimeric Constructions in Vaccines

SYSTEM AND METHOD

BETACORONAVIRUS ATTENUATED STRAIN

CORONAVIRUSES, VACCINES COMPRISING THE SAME, AND METHODS FOR PREVENTING DISEASE

ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION

RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE

A VACCINE FOR CORONAVIRUS AND INFLUENZA VIRUS, AND METHOD FOR PREPARATION THEREOF

ATTENUATED ALPHAVIRUS

COMPOSITIONS AND METHODS FOR THERAPEUTIC OR VACCINE DELIVERY

HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS

RECOMBINANT NEWCASTLE DISEASE VIRUS (rNDV) VECTORS AND METHODS OF USING THE SAME

TROPICAL DISEASE VACCINES

ATTENUATION METHOD OF INFLUENZA VIRUS, ATTENUATED INFLUENZA VIRUS STRAIN, AND USE THEREOF

Novel Adjuvant Compositions

RECOMBINANT VIRUS CONTAINING DEGRON, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

E PROTEIN-MUTATED WEST NILE VIRUS USED AS LIVEATTENUATED VACCINE AND ONCOLYTIC DRUG FOR CANCER THERAPY

SMALLPOX VACCINE FOR CANCER TREATMENT

ATTENUATED MUMPS VACCINE AND USES THEREOF

RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF

DEOPTIMIZED SARS-COV-2 VARIANTS AND METHODS AND USES THEREOF

RNA-ONLY DERIVED ORTHOMYXOVIRUSES AND ASSOCIATED VECTORS AND USES THEREOF

REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE

DEOPTIMIZED YELLOW FEVER VIRUS AND METHODS AND USES THEREOF

VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION

IN-SITU AND REAL-TIME GENERATION AND ADMINISTRATION OF VIRAL VACCINES USING UV LIGHT INACTIVATION

Attenuated Porcine Epidemic Diarrhea Virus

RABIES VIRUS VACCINE

Combination Therapy for Treating Cancer with an Intravenous Administration of a Recombinant MVA and an Immune Checkpoint Antagonist or Agonist

COMPOSITIONS AND METHODS TO INCREASE CORONAVIRUS IMMUNE RESPONSE

Coxsackievirus 83 Vaccine

MESENCHYMAL STEM CELLS AS VACCINE ADJUVANTS AND METHODS FOR USING THE SAME

COMBINED AGONIST ADJUVANT FOR CORONAVIRUS VACCINE

Coronavirus Constructs and Vaccines

LIVE-ATTENUATED VIRUS VACCINE

ARENAVIRUSES FOR USE IN THE TREATMENT AND/OR PREVENTION OF TUMORS AND METHOD FOR PRODUCING ARENAVIRUSES WITH (IM-PROVED) TUMOR-REGRESSION PROPERTIES

Kaposi sarcoma associated herpesvirus gene function

Use of Ectromelia Virus for Cancer Immunotherapy and Vaccines

METHODS AND COMPOSITION FOR INDUCING AN IMMUNE RESPONSE BY A RECOMBINNAT VACCINIA VIRUS

ADENOVIRAL VECTORS AND VACCINES THEREOF

REPLICATION-COMPETENT CONTROLLED HERPESVIRUSES EXPRESSING A SARS COV-2 ANTIGEN

ATTENUATED VIRUSES USEFUL FOR VACCINES

LARGE-SCALE FLAVIVIRAL VACCINE PRODUCTION AND MANUFACTURE

Prefusion RSV F proteins and their use

ENGINEERED INFLUENZA VIRUSES EXPRESSING SARS-COV-2 ANTIGENS, VACCINES AND METHODS OF MAKING AND USING THE SAME

IMMUNOGENIC COMPOSITIONS OF HEPATITIS C VIRUS AND USES THEREOF

PSEUDORABIES VIRUS VACCINE

METHOD FOR THE PROPHYLAXIS OR TREATMENT OF CORONAVIRUS INFECTION USING AN IMMUNOMODULATOR AND VACCINE COMPOSITIONS COMPRISING THE SAME

VIRUS VACCINE BASED ON VIRUS SURFACE ENGINEERING PROVIDING INCREASED IMMUNITY

Adenovirus SARS-CoV-2 Vaccine

ZIKA/DENGUE VACCINE AND APPLICATION THEREOF

METHOD OF ELICITING AN IMMUNE RESPONSE AGAINST RESPIRATORY SYNCYTIAL VIRUS

ATTENUATED REOVIRUS-BASED VACCINE COMPOSITION AND USE THEREOF

N PROTEIN EPITOPE MUTATION MARKER FOR PREPARING EPITOPE DELETION-MARKED VACCINE STRAIN OF TYPE II PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) AND USE THEREOF

Formulations of dengue virus vaccine compositions

ATTENUATED AFRICAN SWINE FEVER VIRUS AND ITS USE AS A VACCINE

NOVEL REPLICATION DEFICIENT INFLUENZA A VIRUS INDUCING HIGH LEVELS OF TYPE I INTERFERON

Zika virus vaccine

Neuraminidase-Inhibited Influenza Virus

COMBINED VACCINE AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS AND METHOD THEREOF FOR INDUCING IMMUNE RESPONSE

Vaccine Product

Development of dengue virus vaccine components

RSV VACCINES AND METHODS OF ADMINISTERING SAME

TRI-SEGMENTED ARENAVIRUSES AS VACCINE VECTORS

COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF

HERPES SIMPLEX VIRUS TYPE 1 DERIVED INFLUENZA VACCINE

Recombinant Ranavirus, Methods of Production, and Its Use As A Mammalian Expression System

Attenuated Virus of Flavivirus Virus and Use Thereof

METHODS OF PRODUCING ADENOVIRUS

Vaccine Composition for Preventing Tuberculosis Comprising Chorismate Mutase

MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY

Prefusion RSV F proteins and their use

COMPOUNDS AND THEIR USE AS VACCINE ADJUVANTS

Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same

Canine Parvovirus

MVA vaccine for delivery of a UL128 complex and preventing CMV infection

System and method directed to an eyeglasses-type wearable device

ATTENUATED POXVIRUS VECTOR BASED VACCINE FOR PROTECTION AGAINST COVID-19

TEMPERATURE-SENSITIVE BETACORONAVIRUS STRAIN AND VACCINE

BETA CORONAVIRUS COLD ACCLIMATIZED STRAIN AND VACCINE

UNIVERSAL MAMMALIAN INFLUENZA VACCINE

COMPOSITIONS AND METHODS OF USE THEREOF FOR PREVENTION AND TREATMENT OF INFLUENZA INFECTIONS

INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES

PARTICLES, DNA & RNA

NOVEL ERYTHROPARVOVIRUS ASSOCIATED WITH RESPIRATORY DISTRESS IN EQUINE

A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIG

AVIAN INFLUENZA VACCINES AND METHODS OF MAKING SAME

MODIFIED MYCOBACTERIUM BOVIS VACCINES

Modified Marek's disease virus, and vaccines made therefrom

A LIVE ATTENUATED MEASLES VIRUS VECTORED VACCINE FOR SARS-COV-2

Recombinant RSV with silent mutations, vaccines, and methods related thereto

RECOMBINANT VIRUSES EXPRESSING ALPHA-1, 3-GALACTOSYLTRANSFERASE AND USES THEREOF

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3

Chimeric RSV, immunogenic compositions, and methods of use

Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof

STABLE FORMULATIONS OF CYTOMEGALOVIRUS

USE OF A BIRNAVIRUS FOR THE TREATMENT OF A DISEASE CAUSED BY VARICELLA ZOSTER VIRUS (VZV)

Replication-competent controlled alpha-herpesvirus vectors and uses therefore

Modulation of replicative fitness by deoptimization of synonymous codons

COMPOSITIONS AND METHODS FOR STABILIZING FLAVIVIRUSES WITH IMPROVED FORMULATIONS

ONCOLYTIC VIRUS VACCINE AND DRUG FOR TREATING TUMORS BY COMBINING ONCOLYTIC VIRUS VACCINE WITH IMMUNE CELLS

CHIMERIC RSV AND CORONAVIRUS PROTEINS, IMMUNOGENIC COMPOSITIONS, AND METHODS OF USE

CORONAVIRUS VACCINES

Zika virus vaccine

ATTENUATED VARIANT OF THE RIFT VALLEY FEVER VIRUS, COMPOSITION COMPRISING SAME, AND USES THEREOF

CORONAVIRUS RNA REPLICONS AND USE THEREOF AS VACCINES

Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating Cancer

CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE

Zika Vaccines and Methods of Use

INFECTIOUS BRONCHITIS (IB) VIRUS VARIANTS AND RELATED COMPOSITIONS, USES AND METHOD

ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR FOR TREATING TUMORS

CMV VACCINES

RECOMBINANT CLASSICAL SWINE FEVER VIRUS

Compositions and methods for dengue virus chimeric constructions in vaccines

Smallpox vaccine for cancer treatment

Target sequence of RNA virus and use thereof

T CELL EPITOPE CLUSTERS AND RELATED COMPOSITIONS USEFUL IN THE PREVENTION, DIAGNOSIS, AND TREATMENT OF COVID-19

Burkholderia pseudomallei complex outer membrane vesicles as adjuvants

A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE

VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION

VACCINE AGAINST AFRICAN SWINE FEVER VIRUS INFECTION

CORONAVIRUS VACCINES COMPOSITIONS AND METHOD OF USING SAME

DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES THEREOF

SYSTEMS AND METHODS FOR GENERATING IMMUNE RESPONSES IN SUBJECTS USING MICROCHANNEL DELIVERY DEVICES

NON-NEUROINVASIVE VIRUSES AND USES THEREOF

Methods of vaccine administration

Formulations of dengue virus vaccine compositions

Virus purification

COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER

Influenza virus vectors and uses therefor

Prostate neoantigens and their uses

Virus and antigen conjugation

MEASLES-VECTORED COVID-19 IMMUNOGENIC COMPOSITIONS AND VACCINES

SYNTHETIC CHIMERIC POXVIRUSES

ATTENUATED AVIAN REOVIRUS STRAINS 94826 C140 AND 97139 C140

Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

System and method for virtual image adjustment

Influenza virus mutants and uses therefor

CHIMERIC FILOVIRUS VACCINES

ENGINEERED NEWCASTLE DISEASE VIRUS VECTOR AND USES THEREOF

Live Attenuated Universal Influenza Virus Vaccines, Methods and Uses Thereof

LASSAVIRUS VACCINES

Buffer Free, Acid Stable Low Dose Volume Rotavirus Vaccine

Recombinant varicella-zoster virus (VZV) vaccine

Attenuating viral mutations in protein genes

INACTIVATED VACCINE FOR CHIKUNGUNYA VIRUS

ATTENUATED DENGUE VIRUSES

AD35-vectored immunogenic composition for SARS-COV-2 infection

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

Recombinant RSV live vaccine strain and the preparing method thereof

RSV vaccines and methods of production and use thereof

SINGLE SHOT CHIKUNGUNYA VIRUS VACCINE

North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof

ATTENUATED VIRUSES USEFUL FOR VACCINES

Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning

Immunogenic Antigens

CHIKUNGUNYA VACCINE FORMULATIONS

INACTIVATION OF PATHOGENS USING METAL-BASED COORDINATION COMPLEXES, AND METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MICROBIAL AND/OR VIRAL INFECTIONS

Zika virus vaccine

METHODS FOR GROWING AFRICAN SWINE FEVER VIRUS IN FETAL PORCINE LUNG ALVEOLAR MACROPHAGE CELLS

PROTEOLYSIS-TARGETING VIRUS, LIVE VACCINE THEREOF, PREPARATION METHOD AND USE THEREOF

Development of dengue virus vaccine components

SENECAVIRUS A VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM

VACCINES AGAINST GENITAL HERPES SIMPLEX INFECTIONS

INFLUENZA VIRUS BACKBONE

ATTENUATED YELLOW FEVER VIRUS AND USES THEREOF FOR THE TREATMENT OF CANCER

RECOMBINANT NON-STRUCTURAL PROTEIN 1, RECOMBINANT INFLUENZA VIRUS AND IMMUNOLOGICAL COMPOSITION INCLUDING THE SAME, AND METHOD OF TREATING OR PREVENTING DISEASE OR CONDITION CAUSED BY OR ASSOCIATED WITH INFLUENZA VIRUS

Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

LIVE ATTENUATED INFLUENZA VACCINE COMPOSITION AND PROCESS FOR PREPARATION THEREOF

USE OF MVA OR MVADELTAE3L AS IMMUNOTHERAPEUTIC AGENTS AGAINST SOLID TUMORS

H5N6 recombinant influenza virus, a composition for preparing the same, and a vaccine composition containing the same

Recombinant virus with diminished latency and methods of using same

RSV-BASED VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION AND USE THEREOF

Genomic deletion in African swine fever vaccine allowing efficient growth in stable cell lines

Dengue virus vaccine

VIRUS-LIKE PARTICLES

Herpesvirus compositions and related methods

Multivalent Live-attenuated Influenza Vaccine for Prevention and Control of Equine Influenza Virus (EIV) in Horses

NOVEL RECOMBINANT INFLUENZA VIRUS HAVING IMMUNE AND THERAPEUTIC RESPONSES TO HETEROLOGOUS INFLUENZA A VIRUS, AND GENETIC VECTOR AND THERAPEUTIC VACCINE COMPRISING SAME

Immunogenic Antigens

VIRUS COMPOSITIONS

Method for Restoring Immune Tolerance In Vivo

Attenuated isolate of infectious bronchitis virus strain DMV1639

Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens

CHIMERIC ONCOLYTIC HERPESVIRUS THAT STIMULATES AN ANTITUMOR IMMUNE RESPONSE

Methods and compositions for inducing protective immunity against filovirus infection

VIRUS VACCINE

Multivalent vaccines for rabies virus and coronaviruses

Chimpanzee adenoviral vector-based filovirus vaccines

Human cytomegalovirus comprising exogenous antigens

Prefusion RSV F proteins and their use

RECOMBINANT VIRUSES AND THE USES THEREOF

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

Compositions and methods for dengue virus chimeric constructions in vaccines

PRODUCTION OF VIRAL VACCINES ON AN AVIAN CELL LINE

Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same

Human rotavirus G9P[6] strain and use as a vaccine

Alphavirus nsP mutants as vaccines

Prime-boost vaccination regimen

Live attenuated influenza B virus compositions methods of making and using thereof

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3

Attenuated virus mutated at sites of evolutionarily conserved RNA structure

ARTHROGENIC ALPHAVIRUS VACCINE

Localized activation of virus replicatio boosts herpesvirus-vectored vaccines

Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof

Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine

virulence factor compositions

Virtual assistant focused user interfaces

Method of Vaccination for SARS Virus

RECOMBINANT RSV LIVE VACCINE STRAIN AND PRODUCTION METHOD THEREFOR

Vaccines for recurrent respiratory papillomatosis and methods of using the same

Chimeric flavivirus lyssavirus vaccines

Method for the prophylaxis or treatment of coronavirus infection using an immunomodulator and vaccine compositions comprising the same

COMPOSITIONS AND METHODS FOR PREVENTING OR AMELIORATING NEONATAL HSV INFECTION

Apparatus for releasably holding a socket

Adjuvant compositions

THERAPEUTIC VACCINE FOR THE TREATMENT OF PAPILLOMAVIRUS LESIONS

DNA PLASMID-LAUNCHED LIVE-ATTANUATED VACCINES FOR PLUS-SENSE SINGEL STRANDED RNA

GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION

Vaccine to pathogenic immune activation cells during infections

VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RNA VIRUSES

Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3

Human rotavirus strains and vaccines

Isolation of a novel pestivirus causing congenital tremor A

Recombinant multivalent influenza viruses

STABLE FORMULATIONS OF CYTOMEGALOVIRUS

ATTENUATED POXVIRUS VECTOR BASED VACCINE FOR PROTECTION AGAINST COVID-19

Attenuated virus strain and use thereof as a vaccine

Recombinant rotavirus expression system and recombinant rotaviruses

METHODS AND COMPOSITIONS FOR ALPHAVIRUS VACCINE

Rapid and prolonged immunologic-therapeutic

COMPOSITIONS AND METHODS COMPRISING MEASLES VIRUS DEFECTIVE INTERFERING PARTICLES FOR THE PREVENTION OF INFECTIOUS DISEASES

Vaccines comprising mutant attenuated influenza viruses

COMPOSITIONS IMMUNOGENIC AGAINST SARS CORONAVIRUS 2, METHODS OF MAKING, AND USING THEREOF

Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

Self-attenuated prophylactic and therapeutic vaccines against pathogens

COMPOSITIONS AND METHODS OF VACCINATION AGAINST DENGUE VIRUS IN CHILDREN AND YOUNG ADULTS

USE OF BETA-GLUCAN EXTRACT IN IMMUNOPOTENTIATION OF AN AVIAN ANIMAL

HCMV vaccine strain

Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer